Abstract:OBJECTIVE:To explore the value of telomerase targeted radiolabeled small interference RNA (siRNA) in tumor imaging in vivo.METHODS:Human telomerase reverse transcriptase (hTERT)-targeted and human gene non-targeted siRNAs were chemically synthesized. Through the conjugation with the chelator N-hydroxysuccinimidyl derivative of S-acetylmercaptoacetyltriglycine (NHS-MAG3), the siRNAs were radiolabeled with technetium-99m ((99m)Tc). HE staining and immunohistochemical staining were used to identify their pathological characteristics. 7.4 MBq of (99m)Tc-siRNAs were injected via the tail vein of hepatocarcinoma bearing mice. At 0.5, 1, 3, and 6 h post injection, the mice were laid on a face-up detector and imaged by single-photon emission computed tomography (SPECT), respectively. The ratio of radioactive counts in tumor to that in the contralateral equivalent region was calculated by drawing regions of interest (ROI) at each time point. After the administration of 7.4 MBq of (99m)Tc-siRNAs, the biodistribution (%ID/g) of tumors and blood was measured at the end of 2, 4 and 6 h. Statistical comparisons of the variables were performed by t-test.RESULTS:The labeling efficiency reached 73.4% ± 3.0%. After purification, the radiochemical purity was no less than 92% and the specific activity was up to 25.9 GBq/μmol. HE staining showed pathological mitotic figure in the nucleus of the tumor cells. hTERT immunohistochemical staining showed deep brown dyed spots in the cell nucleus. hTERT-targeted (99m)Tc-siRNA administrated xenografts showed tumor images clearly after the administration, especially at 6 h. In contrast, (99m)Tc-control-siRNA showed no tumor image. The ratios of uptake in tumor to that in contralateral region of hTERT-targeted siRNA increased from 2.68 ± 0.21 to 5.86 ± 0.30 at 6 h, whereas those of control siRNA decreased from 1.55 ± 0.16 to 1.28 ± 0.12 (P<0.01). The biodistribution of tumors in the hTERT-targeted mice increased from 0.71 ± 0.14 to 0.97 ± 0.15 at 6 h, whereas that in the control mice decreased.CONCLUSION:(99m)Tc radiolabeled telomerase-targeted siRNA probe allows for noninvasive visualization of tumor telomerase in vivo.

A novel near-infrared fluorescent probe for specific imaging of telomerase reverse transcriptase in vivo

Intracellular Fluorescent Light-Up Bioprobes with Different Morphology for Image-Guided Photothermal Cancer Therapy

A Robust Probe for Lighting Up Intracellular Telomerase Via Primer Extension to Open a Nicked Molecular Beacon.

Real-time in situ fluorescence imaging of telomerase and miR378 in living cells using two-color DNA tetrahedron nanoprobe combined with molecular beacons

A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM

A novel highly sensitive fluorescent probe for bioimaging biothiols and its applications in distinguishing cancer cells from normal cells.

Reliable Förster Resonance Energy Transfer Probe Based on Structure-Switching DNA for Ratiometric Sensing of Telomerase in Living Cells.

An Amplified Fluorescence Biosensor for Intracellular Telomerase Determination and in Situ Imaging Based on Thioflavin T and Conjugated Polymer Nanoparticles

A novel molecular probe:experimental study in vivo in nude mice bearing tumor

A Tumor-Targeting and Polarity-Specific Near-Infrared Fluorescent Probe for Accurate Cancer Diagnosis in Vivo

A novel near-infrared theranostic probe for accurate cancer chemotherapy <i>in vivo</i> by a dual activation strategy

A novel DNA tetrahedron-hairpin probe for in situ"off-on" fluorescence imaging of intracellular telomerase activity

Molecular imaging of telomerase and the enzyme activity-triggered drug release by using a conformation-switchable nanoprobe in cancerous cells

[In-Vivo Tumor Imaging by Radiolabeled RNA Probe Targeting Telomerase].

Visually Intracellular Detection of Telomerase Activity Based on DNA Strand Displacement Reaction and Gold Nanoparticle Labeling

Gold Nanobipyramids As Dual-Functional Substrates for in Situ "turn On" Analyzing Intracellular Telomerase Activity Based on Target-Triggered Plasmon-Enhanced Fluorescence.

Molecular Imaging and Pharmacokinetics of (99m) Tc-hTERT Antisense Oligonucleotide As a Potential Tumor Imaging Probe.

Facilitating In Situ Tumor Imaging with a Tetrahedral DNA Framework‐Enhanced Hybridization Chain Reaction Probe

Smart Vesicle Kit for in Situ Monitoring of Intracellular Telomerase Activity Using a Telomerase-Responsive Probe.

In Situ Detection and Imaging of Telomerase Activity in Cancer Cell Lines Via Disassembly of Plasmonic Core-Satellites Nanostructured Probe.

Visual detection of telomerase activity with a tunable dynamic range by using a gold nanoparticle probe-based hybridization protection strategy